Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
70.54
-0.11 (-0.16%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $473.48 million as of October 26, 2026. It is the 14,884th most valuable company in the world and the 2,774th biggest in the United States. Its market cap has decreased by 19.43% in one year.
Market Cap
473.48M
Enterprise Value
339.38M
1-Year Change
-19.43%
Global Rank
Country Rank
#2,774 United States
Category
ChartMarket Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $473.48M, an increase of 71.45%. That is a compound annual growth rate of 8.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 473.48M | 8.50% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 493.97M |
| Oculis Holding AG | 487.68M |
| Indaptus Therapeutics | 485.32M |
| Arvinas | 477.32M |
| Neurogene | 471.27M |
| DiaMedica Therapeutics | 470.23M |
| BlossomHill Therapeutics | 465.01M |
| Phathom Pharmaceuticals | 455.93M |